What is Biohaven's other financing?

Biohaven (BHVN) reported other financing of $0 in Q1 2026.

What is the long-term trend for Biohaven's other financing?

Over 3 years (2021 to 2025), Biohaven's other financing has grown at a -21.1% compound annual growth rate (CAGR), from $395K to -$194K.

What does other financing mean?

Miscellaneous financing cash flows not classified in specific line items.

Biohaven BHVN Other Financing

Other Financing at other companies

Eli LillyLLY

-$591M+13.8%

uniQureQURE

-$1.34M-210%

BiogenBIIB

$11.3M+769%

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.25B-48.1%

Enterprise value$2.26B-46.3%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's other financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biohaven's other financing?: Biohaven (BHVN) reported other financing of $0 in Q1 2026.
What is the long-term trend for Biohaven's other financing?: Over 3 years (2021 to 2025), Biohaven's other financing has grown at a -21.1% compound annual growth rate (CAGR), from $395K to -$194K.
What does other financing mean?: Miscellaneous financing cash flows not classified in specific line items.